Why the study?
Non-obstructive coronary artery disease occurs in 3.5–15% of patients presenting with acute myocardial infarction and confers a poor prognosis, making the identification of factors predicting worse outcomes in MINOCA important.
In patients with MINOCA, older age, type 2 diabetes, specific ECG abnormalities, higher Gensini score, myocardial hypertrophy, and history of neoplasm are significant predictors of adverse long-term cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
Identified predictors in this small retrospective cohort may signal higher risk; leaves open whether they guide targeted interventions in MINOCA.
Non-obstructive coronary artery disease occurs in 3.5–15% of patients presenting with acute myocardial infarction. This group of patients has a poor prognosis. Identification of factors that predict worse outcomes in myocardial infarction with non-obstructive coronary arteries (MINOCA) is therefore important. Patients with a diagnosis of MINOCA (n = 110) were enrolled in this single-center, retrospective registry. Follow-up was performed 12, 24 and 36 months after discharge. The primary composite endpoint was defined as myocardial infarction, coronary revascularization, stroke or TIA, all-cause death, or hospital readmission due to any cardiovascular event. The mean age of the study group was 64.9 (± 13.5) years and 38.2% of patients were male. The occurrence of the primary composite endpoint was 36.4%. In a COX proportional hazards model analysis, older age (p = 0.027), type 2 diabetes (p = 0.013), history of neoplasm (p = 0.004), ST-segment depression (p = 0.018) and left bundle branch block/right bundle branch block (p = 0.004) by ECG on discharge, higher Gensini score (p = 0.022), higher intraventricular septum (p = 0.007) and posterior wall thickness increases (p = 0.001) were shown to be risk factors for primary composite endpoint occurrence. Our study revealed that several factors such as older age, type 2 diabetes, ST-segment depression and LBBB/RBBB in ECG on discharge, higher Gensini score, and myocardial hypertrophy and history of neoplasm may contribute to worse clinical outcomes in MINOCA patients.
No takes yet. Share an insight, caveat, or question.
Szolc et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: